US · Healthcare · Medical Distribution
EPS came in at 9.93 against a street estimate of 9.44 — a beat of 5.2%.
Analysts rate McKesson Corporation a buy (13 buy, 3 hold, 1 sell out of 17) with an average price target of $980.73.
CONFIDENT MCK beat Q1 FY27 expectations with 8% revenue growth to $105.4B and 20% EPS growth to $9.93. Raised full-year EPS guidance to $44.20–$45.00. Three segments posted double-digit profit growth; oncology surged 41% AOP. Q1 FY27 Company operates primarily in North America with portfolio actions focused on U.S. markets. Norway divestiture completed January 2026. Analysts pressed on NAP margin sustainability, O&M organic growth durability, and free cash flow lagging earnings. Management credited mix favorability, geographic expansion, and structural working capital gains; guided conservatively, not aggressively. 2026-08-05…
Full summary in the app.
| Fund | Stake |
|---|---|
| BlackRock Inc | 9.79% |
| Vanguard Capital Management, LLC | 6.83% |
| State Street Corp | 4.92% |
| FMR Inc | 3.09% |
| JPMorgan Chase & Co | 2.80% |
| Franklin Templeton Inc | 2.63% |
| Geode Capital Management, LLC | 2.49% |
| Massachusetts Financial Services Company | 2.49% |
| Document | Date |
|---|---|
| Reg FD disclosure · Q2 FY2027 MCKESSON CORPORATION – FORM 8-K SUMMARY Filing Date: August 28, 2026 | Event Date: August 25, 2026 --- HEADLINE NUMBERS • Company: McKESSON CORPORA | 2026-08-28 |
| Quarterly report · Q1 FY2027 MCKESSON CORPORATION – Q1 FY2027 (10-Q) SUMMARY --- HEADLINE NUMBERS • Revenues: $105,380 million (Q1 FY2027) vs. $97,827 million (Q1 FY2026) — +7. | 2026-08-05 |
| Results announced · Q2 FY2027 McKESSON CORPORATION – FISCAL 2027 Q1 RESULTS SUMMARY --- HEADLINE NUMBERS • Consolidated revenues: $105.4 billion, up 8% year-over-year • Adjusted | 2026-08-05 |
| Shareholder vote results · Q2 FY2027 MCKESSON CORPORATION FORM 8-K SUMMARY Annual Shareholder Meeting Results – July 22, 2026 --- HEADLINE NUMBERS • Total shares voted: Approximately 1 | 2026-07-24 |
| Board / officer change · Q1 FY2027 MCKESSON CORPORATION (MCK) - FORM 8-K SUMMARY HEADLINE NUMBERS • No financial metrics, earnings data, or revenue figures disclosed in this filing • D | 2026-07-01 |
| Proxy statement · Q4 FY2026 MCKESSON CORPORATION – PROXY STATEMENT SUMMARY HEADLINE NUMBERS • Total Revenues FY 2026: Exact figure not provided in excerpt, but shows growth tra | 2026-06-12 |
| Annual report FY2026 McKESSON CORPORATION – FORM 10-K SUMMARY Fiscal Year Ended March 31, 2026 --- HEADLINE NUMBERS • Market Capitalization (as of September 30, 2025): | 2026-05-08 |
| Quarterly report · Q3 FY2026 MCKESSON CORPORATION - Q3 FY2026 10-Q SUMMARY HEADLINE NUMBERS • Nine-month revenues (ended Dec 31, 2025): $307.1 billion, up from $268.2 billion in | 2026-02-04 |
Readable in the app.
| Action | Detail | Date |
|---|---|---|
| Dividend | $0.94 / share ex-date Sep 1, 2026 · pay Oct 1, 2026 | 2026-09-01 |
| Dividend | $0.82 / share ex-date Jun 1, 2026 · pay Jul 1, 2026 | 2026-06-01 |
| Dividend | $0.82 / share ex-date Mar 2, 2026 · pay Apr 1, 2026 | 2026-03-02 |
| Dividend | $0.82 / share ex-date Dec 1, 2025 · pay Jan 2, 2026 | 2025-12-01 |
| Dividend | $0.82 / share ex-date Sep 2, 2025 · pay Oct 1, 2025 | 2025-09-02 |
| Announcement | Date |
|---|---|
| Fiscal 2026 guidance and long-term targets updated at Investor Day McKesson Corporation issued updated Fiscal 2026 guidance and long-term targets on September 23, 2025, during its Investor Day event. The company disclosed this information through a news rel | 2025-09-23 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for McKesson Corporation — free to start.
Google PlayApp StoreData updated 2026-09-18.